Challenges in Cost-Effectiveness Analysis Modelling of HPV Vaccines in Low- and Middle-Income Countries: A Systematic Review and Practice Recommendations

被引：0
|
作者：
Obinna I. Ekwunife
James F. O’Mahony
Andreas Gerber Grote
Christoph Mosch
Tatjana Paeck
Stefan K. Lhachimi
机构：
[1] BIPS/University of Bremen,Collaborative Research Group for Evidence
[2] Nnamdi Azikiwe University,Based Public Health, Department of Prevention and Evaluation, Leibniz Institute for Prevention Research and Epidemiology
[3] Trinity College Dublin,Department of Clinical Pharmacy and Pharmacy Management
[4] University of Cologne,Centre for Health Policy and Management, School of Medicine
[5] Universität Witten/Herdecke,Institute for Health Economics and Clinical Epidemiology
[6] ZHAW,Institute for Research in Operative Medicine (IFOM)
[7] University of Bremen,Department of Health
来源：
PharmacoEconomics | 2017年 / 35卷
关键词：
Cervical Cancer; Coverage Rate; Cervical Cancer Screening; Vaccine Coverage; Cervical Cancer Prevention;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：65 / 82
页数：17
相关论文
共 50 条
  • [41] Costs and cost-effectiveness of influenza illness and vaccination in low- and middle-income countries: A systematic review from 2012 to 2022
    Gharpure, Radhika
    Chard, Anna N.
    Escobar, Maria Cabrera
    Zhou, Weigong
    Valleau, Molly M.
    Yau, Tat S.
    Bresee, Joseph S.
    Azziz-Baumgartner, Eduardo
    Pallas, Sarah W.
    Lafond, Kathryn E.
    PLOS MEDICINE, 2024, 21 (01)
  • [42] Comment on: “Are Current Cost-Effectiveness Thresholds for Low- and Middle-Income Countries Useful? Examples from the World of Vaccines”
    Afschin Gandjour
    PharmacoEconomics, 2014, 32 : 1245 - 1246
  • [43] Potential impact and cost-effectiveness of future ETEC and Shigella vaccines in 79 low- and lower middle-income countries
    Anderson, John D.
    Bagamian, Karoun H.
    Muhib, Farzana
    Baral, Ranju
    Laytner, Lindsey A.
    Amaya, Mirna
    Wierzba, Thomas
    Rheingans, Richard
    VACCINE: X, 2019, 2
  • [44] Comment on: "Are Current Cost-Effectiveness Thresholds for Low- and Middle-Income Countries Useful? Examples from the World of Vaccines"
    Gandjour, Afschin
    PHARMACOECONOMICS, 2014, 32 (12) : 1245 - 1246
  • [45] The cost-effectiveness of hypertension management in low-income and middle-income countries: a review
    Kostova, Deliana
    Spencer, Garrison
    Moran, Andrew E.
    Cobb, Laura K.
    Husain, Muhammad Jami
    Datta, Biplab Kumar
    Matsushita, Kunihiro
    Nugent, Rachel
    BMJ GLOBAL HEALTH, 2020, 5 (09):
  • [46] HPV vaccinations in low- and middle-income countries
    Baghi, Hossein Bannazadeh
    Aghazadeh, Mohammad
    AMERICAN JOURNAL OF INFECTION CONTROL, 2018, 46 (02) : 244 - 244
  • [47] Effectiveness of Cardiac Rehabilitation Services in Low- and Middle-Income Countries: A Systematic Review
    Mbau, Lilian
    Prabhakar, Prabhakar Mallya
    Khan, Zahid
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (12)
  • [48] Effectiveness of hospital payment reforms in low- and middle-income countries: a systematic review
    Ghazaryan, Emma
    Delarmente, Benjo A.
    Garber, Kent
    Gross, Margaret
    Sriudomporn, Salin
    Rao, Krishna D.
    HEALTH POLICY AND PLANNING, 2021, 36 (08) : 1344 - 1356
  • [49] Cost of illness of breast cancer in low- and middle-income countries: a systematic review
    Yeong, Siew Wei
    Lee, Sit Wai
    Ong, Siew Chin
    HEALTH ECONOMICS REVIEW, 2024, 14 (01):
  • [50] Costs and cost-effectiveness of HIV early infant diagnosis in low- and middle-income countries: a scoping review
    Elsbernd, Kira
    Emmert-Fees, Karl M. F.
    Erbe, Amanda
    Ottobrino, Veronica
    Kroidl, Arne
    Barnighausen, Till
    Geisler, Benjamin P.
    Kohler, Stefan
    INFECTIOUS DISEASES OF POVERTY, 2022, 11 (01)
12345